JOHNSON AND JOHNSON News & Analysis

Japan rocked by attack on former Prime Minister while on campaign trail.

Three new vaccines for coronavirus look poised for emergency use authorisation in the US this autumn. What does that mean for investors?

Opportunistic investors could consider several companies with infectious disease and vaccine expertise.

When do you buy? When do you sell? How do you get the price you want? It is always a good time to brush up on what constitutes good hygiene when...

A new Morningstar report identifies which big-name health companies are inoculated against environmental, social and governance risks.

Sterling and UK shares surged as the scale of the Conservative party’s victory emerged last Friday, writes Morningstar UK's James Gard.\n 

Morningstar Investment Management's Mike Coop looks at the likely impact of the Conservative election win on UK equities.

With a General Election slated for December and Brexit postponed until 2020, investors should consider how their portfolios are positioned for more...

Britain’s ongoing Brexit saga has seemingly failed to spook investors, despite Boris Johnson’s failed pledge to quit the European Union by Halloween.

The new UK Prime Minister is expected to cut taxes and boost spending, but a lack of clarity on Brexit is holding back UK shares and the pound.